• Atea Pharmaceuticals Inc (AVIR:UW): Stock Price, Quote and News BNN Bloomberg Sat, 04 Jul 2026 13:49:44 GMT
• Atea Pharmaceuticals (AVIR) Q1 2026 Earnings: Beat on EPS Despite Pre-Revenue Status; Stock Climbs 2.67% - Consensus Forecast Repo... dars.gov.et Mon, 29 Jun 2026 22:35:47 GMT
• price to earnings forward of atea pharmaceuticals, inc. – nasdaq:avir TradingView Mon, 29 Jun 2026 05:24:26 GMT
• Price to book forward of Atea Pharmaceuticals, Inc. – NASDAQ:AVIR TradingView Sun, 28 Jun 2026 21:28:32 GMT
• enterprise value to ebitda forward of atea pharmaceuticals, inc. – boats:avir TradingView Sat, 27 Jun 2026 22:03:43 GMT
• atea pharmaceuticals inc (avir) technical analysis: support, resistance, indicators & moving averages TradingKey Sat, 27 Jun 2026 10:17:08 GMT
• down 25% in 4 weeks, here's why atea pharmaceuticals (avir) looks ripe for a turnaround MSN Sat, 27 Jun 2026 08:17:23 GMT
• avir sec filings - atea pharmaceuticals, inc. 10-k, 10-q, 8-k forms Stock Titan Fri, 26 Jun 2026 22:30:29 GMT
• atea pharmaceuticals (nasdaq:avir) refocuses antiviral pipeline Kalkine Media Fri, 26 Jun 2026 19:55:00 GMT
• Atea Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:AVIR) TradingView Fri, 26 Jun 2026 13:15:44 GMT
• atea pharmaceuticals inc (avir) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 26 Jun 2026 09:55:44 GMT
• atea completes enrollment in phase 3 hepatitis c trial Investing.com UK Thu, 25 Jun 2026 17:31:50 GMT
• Atea Pharmaceuticals Completes Patient Enrollment in Phase GlobeNewswire Thu, 25 Jun 2026 11:00:00 GMT
• akebia therapeutics and 2 other promising penny stocks to watch Sahm Thu, 25 Jun 2026 09:39:33 GMT
• atea pharmaceuticals inc (avir) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• akebia therapeutics and 2 other promising penny stocks to watch simplywall.st Wed, 24 Jun 2026 11:09:26 GMT
• avir sec filings - atea pharmaceuticals, inc. 10-k, 10-q, 8-k forms Stock Titan Wed, 24 Jun 2026 08:25:54 GMT
• form 4 atea pharmaceuticals inc for: 23 june by investing.com Investing.com South Africa Tue, 23 Jun 2026 21:27:17 GMT
• [Form 4] Atea Pharmaceuticals, Inc. Insider Trading Activity Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Director Howard Berman receives new equity awards at Atea (NASDAQ: AVIR) Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Atea Pharmaceuticals (NASDAQ: AVIR) grants options and RSUs to director Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Atea Pharmaceuticals (NASDAQ: AVIR) director reports RSU exercise and new option, RSU grants Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Atea (NASDAQ: AVIR) grants Bruno Lucidi options and new RSUs Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Atea Pharmaceuticals (AVIR) director reports RSU vesting and new option grant Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Atea Pharmaceuticals (AVIR) director receives new options and RSU awards Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Equity awards boost Atea (AVIR) director Barbara Duncan’s holdings Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Atea Shareholders Back Directors, Auditors and Executive Pay The Globe and Mail Tue, 23 Jun 2026 07:00:00 GMT
• Atea Pharmaceuticals elects directors and approves proposals at annual meeting Investing.com UK Mon, 22 Jun 2026 22:50:00 GMT
• atea shareholders back directors, auditors and executive pay TipRanks Mon, 22 Jun 2026 22:27:06 GMT
• Form 8K Atea Pharmaceuticals Inc For: 22 June By Investing.com Investing.com UK Mon, 22 Jun 2026 21:02:00 GMT
• Atea Pharmaceuticals (NASDAQ: AVIR) reports 2026 annual meeting and vote outcomes Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• atea pharmaceuticals (avir) upgraded to buy: here's what you should know MSN Sun, 21 Jun 2026 14:59:04 GMT
• atea pharmaceuticals inc (avir) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• atea pharmaceuticals inc (avir) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 05:57:43 GMT
• atea pharmaceuticals inc (avir) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 10:50:54 GMT
• atea pharmaceuticals inc (avir) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 10:48:09 GMT
• Atea Pharmaceuticals Inc (AVIR) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Thu, 18 Jun 2026 10:20:33 GMT
• Atea Pharmaceuticals (AVIR) Upgraded to Buy: Here's What You Should Know Yahoo Finance Thu, 18 Jun 2026 07:00:00 GMT
• atea pharmaceuticals inc (avir) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• atea pharmaceuticals inc (avir) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• atea pharmaceuticals inc (avir) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• atea pharmaceuticals inc (avir) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• atea pharmaceuticals inc (avir) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 08:01:01 GMT
• atea pharmaceuticals inc (avir) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:58:05 GMT
• atea pharmaceuticals inc (avir) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 07:54:58 GMT
• atea pharmaceuticals inc (avir) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 07:46:56 GMT
• atea pharmaceuticals inc (avir) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 07:21:46 GMT
• avir q1 2026 earnings: narrower-than-expected loss supports ongoing antiviral pipeline development - revenue growth outlook newsline.com Mon, 15 Jun 2026 14:33:00 GMT
• atea pharmaceuticals (avir) price target increased by 33.33% to 8.16 MSN Mon, 15 Jun 2026 10:28:53 GMT
• avir q1 2026 earnings: eps surprise of 5.28% highlights cost discipline amid pre-revenue phase newsline.com Mon, 15 Jun 2026 08:38:42 GMT
• atea pharmaceuticals inc (avir) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year? Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• atea pharmaceuticals (avir) rallies 1.65% as shares test key resistance near $4.54 - scalping stock signals newsline.com Tue, 09 Jun 2026 00:44:12 GMT
• atea pharmaceuticals (avir) rallies 1.65% as shares test key resistance near $4.54 - demand zone dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• atea pharmaceuticals (avir) declines 3.85% as shares approach key support level - pcr mean reversion newsline.com Sun, 07 Jun 2026 20:36:45 GMT
• avir sec filings - atea pharmaceuticals, inc. 10-k, 10-q, 8-k forms Stock Titan Wed, 03 Jun 2026 04:57:52 GMT
• atea pharmaceuticals (avir) price target increased by 33.33% to 8.16 MSN Sat, 30 May 2026 16:03:20 GMT
• Atea Pharmaceuticals - I'm Optimistic Ahead Of Critical HPV Catalyst (NASDAQ:AVIR) Seeking Alpha Fri, 29 May 2026 07:00:00 GMT
• atea pharmaceuticals q1 2026 earnings: eps surprise masks revenue void as shares dip 2.84% - earnings expansion phase dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• atea pharmaceuticals q1 2026 earnings: narrower loss beats expectations; stock edges higher - guidance accuracy score newsline.com Thu, 28 May 2026 07:00:00 GMT
• atea pharmaceuticals rises after hepatitis c data; 2026 readouts eyed Bez Kabli Wed, 27 May 2026 19:29:48 GMT
• Atea Pharmaceuticals Presents New Drug-Drug Interaction GlobeNewswire Wed, 27 May 2026 07:00:00 GMT
• no hepatitis e drugs: atea antiviral 30–150x more potent in lab Stock Titan Wed, 27 May 2026 07:00:00 GMT
• atea pharmaceuticals (avir) holds steady near support amid flat trading session - continuation pattern picks newsline.com Wed, 27 May 2026 07:00:00 GMT
• atea presents hepatitis c drug interaction data at easl by investing.com Investing.com UK Wed, 27 May 2026 07:00:00 GMT
• atea pharma shows low drug interaction risk for new hepatitis c treatment and promising hepatitis e antiviral data. Pluang Wed, 27 May 2026 07:00:00 GMT
• Spotlight On Atea Pharmaceuticals And 2 Other Prominent Penny Stocks Yahoo Finance Mon, 25 May 2026 07:00:00 GMT
• atea pharmaceuticals q1 2026 earnings: narrower loss surprises analysts amid r&d progress - slow growth warning newsline.com Mon, 25 May 2026 07:00:00 GMT
• avir q1 2026 earnings: narrower-than-expected loss boosts investor sentiment - profit warning alert Newser Sat, 23 May 2026 15:36:34 GMT
• atea pharmaceuticals (avir) edges higher amid renewed investor interest - buffered etf Newser Sat, 23 May 2026 02:34:18 GMT
• avir sec filings - atea pharmaceuticals, inc. 10-k, 10-q, 8-k forms Stock Titan Fri, 22 May 2026 15:59:37 GMT
• atea pharmaceuticals (avir) gains 4.25% as stock tests key resistance level - short term trading ideas dars.gov.et Fri, 22 May 2026 07:00:00 GMT
• atea pharmaceuticals (avir) edges higher amid renewed investor interest - tick index newsline.com Fri, 22 May 2026 07:00:00 GMT
• atea pharmaceuticals (avir) shows modest uptick, holding above key support - gex level newsline.com Fri, 22 May 2026 07:00:00 GMT
• atea pharmaceuticals director polly murphy buys $25,446 in stock by investing.com Investing.com Australia Fri, 22 May 2026 07:00:00 GMT
• atea pharma (avir) crushes q1 2026 estimates — eps $-0.57 tops views - senior analyst forecasts Newser Thu, 21 May 2026 09:34:30 GMT
• Atea Pharmaceuticals (AVIR) director buys 6,100 shares of stock Stock Titan Thu, 21 May 2026 07:00:00 GMT
• Top-line Phase 2 trial data for hepatitis C combo therapy expected soon Liver Disease News Thu, 21 May 2026 07:00:00 GMT
• atea pharmaceuticals director polly murphy buys $25,446 in stock Investing.com Thu, 21 May 2026 07:00:00 GMT
• top atea pharmaceuticals insider quietly boosts stake in bold new move TipRanks Thu, 21 May 2026 03:41:30 GMT
• atea (avir) director adds 6,100 shares in open-market purchase Stock Titan Wed, 20 May 2026 07:00:00 GMT
• top atea pharmaceuticals insider quietly boosts stake in bold new move TipRanks Wed, 20 May 2026 07:00:00 GMT
• Here's Why We're Watching Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Situation Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• atea pharma (avir) stock: up +1.69%, key resistance at $4.42 2026-05-19 - dividend stock picks newsline.com Tue, 19 May 2026 07:00:00 GMT
• down 25% in 4 weeks, here's why atea pharmaceuticals (avir) looks ripe for a turnaround MSN Mon, 18 May 2026 17:11:35 GMT
• atea pharma (avir) up +2.20% — is there more room to run? 2026-05-18 - {涓偂鍓爣棰榼 Newser Mon, 18 May 2026 15:02:32 GMT
• earnings call transcript: atea pharmaceuticals q1 2026 reveals stock plunge after eps miss Investing.com UK Mon, 18 May 2026 07:00:00 GMT
• morgan stanley maintains atea pharmaceuticals(avir.us) with hold rating, cuts target price to $4.1 Moomoo Mon, 18 May 2026 07:00:00 GMT
• avir sec filings - atea pharmaceuticals, inc. 10-k, 10-q, 8-k forms Stock Titan Sat, 16 May 2026 08:15:34 GMT
• down 25% in 4 weeks, here's why atea pharmaceuticals (avir) looks ripe for a turnaround Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• atea pharmaceuticals (avir.us) will release its earnings report after the market closes on may 12. Moomoo Fri, 15 May 2026 07:00:00 GMT
• analysts’ opinions are mixed on these healthcare stocks: ibio (ibio), maxcyte (mxct) and atea pharmaceuticals (avir) The Globe and Mail Thu, 14 May 2026 14:03:01 GMT
• We Think Atea Pharmaceuticals (NASDAQ:AVIR) Needs To Drive Business Growth Carefully simplywall.st Thu, 14 May 2026 07:00:00 GMT
• atea pharmaceuticals sets up catalyst-rich 2026 earnings call TipRanks Thu, 14 May 2026 00:35:10 GMT
• atea anticipates phase iii c-beyond midyear and c-forward year-end readouts while projecting cash runway through 2027 MSN Wed, 13 May 2026 09:00:10 GMT
• Atea Pharmaceuticals Announces Three Accepted Abstracts for Presentation at EASL Congress 2026 Quiver Quantitative Wed, 13 May 2026 07:00:00 GMT
• atea pharmaceuticals to present three abstracts at easl GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• new hepatitis c and e drug data headed to easl 2026 congress Stock Titan Wed, 13 May 2026 07:00:00 GMT
• atea pharmaceuticals, inc. (nasdaq:avir) q1 2026 earnings call transcript Insider Monkey Wed, 13 May 2026 07:00:00 GMT
• atea pharmaceuticals, inc. q1 2026 earnings call summary Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• atea pharmaceuticals sets up catalyst-rich 2026 earnings call TipRanks Wed, 13 May 2026 07:00:00 GMT
• atea pharmaceuticals reports first quarter 2026 financial results and provides business update The Manila Times Wed, 13 May 2026 07:00:00 GMT
• earnings call transcript: atea pharmaceuticals q1 2026 reports slight eps miss, stock dips Investing.com Australia Wed, 13 May 2026 07:00:00 GMT
• atea pharmaceuticals q1 2026 earnings call: complete transcript Sahm Wed, 13 May 2026 07:00:00 GMT
• atea pharmaceuticals, inc. 2026 q1 - results - earnings call presentation (nasdaq:avir) 2026-05-12 Seeking Alpha Wed, 13 May 2026 02:02:26 GMT
• [10-q] atea pharmaceuticals, inc. quarterly earnings report Stock Titan Tue, 12 May 2026 20:45:37 GMT
• avir: hcv and hev programs advance toward key milestones as r&d spending drives higher net loss TradingView Tue, 12 May 2026 20:25:49 GMT
• atea pharmaceuticals : q1 26 ir slide deck 5 12 26 final marketscreener.com Tue, 12 May 2026 20:14:37 GMT
• Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• Boston biotech lines up 2026 trials for new hepatitis C and E drugs Stock Titan Tue, 12 May 2026 07:00:00 GMT
• 8-k: atea pharmaceuticals reports first quarter 2026 financial results and provides business update - moomoo Moomoo Tue, 12 May 2026 07:00:00 GMT
• atea pharmaceuticals q1 2026 earnings call: complete transcript Benzinga Tue, 12 May 2026 07:00:00 GMT
• atea (nasdaq: avir) advances hcv, hev pipeline as q1 loss widens Stock Titan Tue, 12 May 2026 07:00:00 GMT
• earnings call transcript: atea pharmaceuticals q1 2026 reports slight eps miss, stock dips Investing.com Canada Tue, 12 May 2026 07:00:00 GMT
• atea pharmaceuticals reports q1 2026 net loss $45.4m, cash & marketable securities $256.0m TradingView Tue, 12 May 2026 07:00:00 GMT
• atea pharmaceuticals, inc. 2026 q1 - results - earnings call presentation (nasdaq:avir) 2026-05-12 Seeking Alpha Tue, 12 May 2026 07:00:00 GMT
• atea pharmaceuticals (nasdaq: avir) widens q1 loss while funding late-stage hcv trials Stock Titan Tue, 12 May 2026 07:00:00 GMT
• atea pharmaceuticals, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 07:00:00 GMT
• atea pharmaceuticals inc (avir) q1 2026 earnings call highlights: strategic advancements and ... by gurufocus Investing.com Canada Tue, 12 May 2026 07:00:00 GMT
• atea pharmaceuticals | 4: statement of changes in beneficial ownership of securities-officer corcoran andrea Moomoo Mon, 11 May 2026 06:36:42 GMT
• atea pharmaceuticals (avir.us) will release its earnings report after the market closes on may 12. 富途牛牛 Thu, 07 May 2026 04:32:50 GMT
• [schedule 13g/a] atea pharmaceuticals, inc. amended passive investment disclosure Stock Titan Wed, 06 May 2026 07:00:00 GMT
• atea pharmaceuticals (avir) price target increased by 25.00% to 10.20 MSN Tue, 05 May 2026 10:35:01 GMT
• avir | atea pharmaceuticals, inc. common insider trading Quiver Quantitative Tue, 05 May 2026 08:02:50 GMT
• Atea Pharmaceuticals to Host First Quarter 2026 Financial GlobeNewswire Tue, 05 May 2026 07:00:00 GMT
• atea pharmaceuticals to report q1 2026 financial results and business update on may 12. Pluang Tue, 05 May 2026 07:00:00 GMT
• atea sets may 12 webcast for quarterly results and business update Stock Titan Tue, 05 May 2026 07:00:00 GMT
Atea Pharmaceuticals, Inc(NASDAQ:AVIR) 
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for th...
Website: http://www.ateapharma.com
CEO: Jean-Pierre Sommadossi
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends